• B-Type Natriuretic Peptide (BNP) or Pro B-Type Natriuretic Peptide (Pro BNP)
  • Beryllium, Serum
  • MUTYH Gene Mutation Analysis (Y165C and G382D) for MUTYH associated polyposis (MAP)
  • Methemoglobin Reductase, Blood
  • CPOX Gene Mutation Analysis
  • Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibody
  • Renin Activity
  • Hereditary Hemolytic Anemia Gene Mutation Panel, NGS
  • Nucleophosmin (NPM1) Gene Mutation Analysis
  • Gout
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Diseases (5)
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.